25
April
2018
|
00:00
Europe/Amsterdam
Concepts for a modern wound care
Summary
Non-swelling foam allows fast fluid transport
2018-036-783028.jpg
Auf dem EWMA Fachkongress stellt Covestro unter anderem die neue wässrige Polyurethandispersion Baymedix® FD103 vor. Daraus hergestellte thermoformbare Schäume für die Wunderversorgung leiten Flüssigkeiten schnell weiter, ohne dabei aufzuquellen. Eine mögliche Anwendung sind tragbare Pflaster, die in Form von Wearable Patch Devices künftig eine wichtige Rolle spielen dürften.
The European Wound Management Association Congress – EWMA – from May 9 to 11, 2018 in Krakow, Poland, is all about providing patients with effective wound care and improving their quality of care.
At the accompanying exhibition, Covestro will be presenting material solutions based on the innovative Baymedix® polyurethane technology, at Booth D406. It enables efficient production of foams, adhesives, films, bandages and medical gloves. A specialty films portfolio from Platilon® completes the offer. The products open up a broad field of application both in modern wound care and in new wearable patch devices.
Foams based on the product Baymedix® FP505 are characterized by very good absorption and excellent retention. This allows optimized moisture management.
New non-swelling, thermoformable foam allows fast fluid transport
In addition, at the 2018 EWMA Congress, Covestro will be presenting thermoformable foams made from the Baymedix® FD103 aqueous dispersion. Thanks to the microporous cell structure, they can quickly transfer fluids without swelling.
The special feature here is that the foams can be applied in thin layers on a carrier material and later molded into shape through heat and pressure.
Portable electronics on the skin
One possible application is the wearable patch. During manufacture, the foam is sealed to the film and a flat electronic circuit is embedded. Consumers use such thin wearable patch devices to measure their body temperature, blood sugar level or heart rate. In sports and leisure they serve to provide fitness data feedback.
The patches offer great market potential, especially for medical diagnostics and treatment of diseases. Thanks to the thin and breathable layer structure and the use of skin friendly adhesives based on Baymedix® A for fixation Covestro contributes to greater comfort for patients. At the same time, the company uses its experience in medical technology to enable a fast, flexible and cost-efficient production of such composites patches.
About Covestro:
With 2017 sales of EUR 14.1 billion, Covestro is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, construction, wood processing and furniture, and electrical and electronics industries. Other sectors include sports and leisure, cosmetics, health and the chemical industry itself. Covestro has 30 production sites worldwide and employs approximately 16,200 people (calculated as full-time equivalents) at the end of 2017.
Find more information at www.covestro.com.
Follow us on Twitter: www.twitter.com/Covestro
Forward-looking statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro’s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
At the accompanying exhibition, Covestro will be presenting material solutions based on the innovative Baymedix® polyurethane technology, at Booth D406. It enables efficient production of foams, adhesives, films, bandages and medical gloves. A specialty films portfolio from Platilon® completes the offer. The products open up a broad field of application both in modern wound care and in new wearable patch devices.
Foams based on the product Baymedix® FP505 are characterized by very good absorption and excellent retention. This allows optimized moisture management.
New non-swelling, thermoformable foam allows fast fluid transport
In addition, at the 2018 EWMA Congress, Covestro will be presenting thermoformable foams made from the Baymedix® FD103 aqueous dispersion. Thanks to the microporous cell structure, they can quickly transfer fluids without swelling.
The special feature here is that the foams can be applied in thin layers on a carrier material and later molded into shape through heat and pressure.
Portable electronics on the skin
One possible application is the wearable patch. During manufacture, the foam is sealed to the film and a flat electronic circuit is embedded. Consumers use such thin wearable patch devices to measure their body temperature, blood sugar level or heart rate. In sports and leisure they serve to provide fitness data feedback.
The patches offer great market potential, especially for medical diagnostics and treatment of diseases. Thanks to the thin and breathable layer structure and the use of skin friendly adhesives based on Baymedix® A for fixation Covestro contributes to greater comfort for patients. At the same time, the company uses its experience in medical technology to enable a fast, flexible and cost-efficient production of such composites patches.
About Covestro:
With 2017 sales of EUR 14.1 billion, Covestro is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, construction, wood processing and furniture, and electrical and electronics industries. Other sectors include sports and leisure, cosmetics, health and the chemical industry itself. Covestro has 30 production sites worldwide and employs approximately 16,200 people (calculated as full-time equivalents) at the end of 2017.
Find more information at www.covestro.com.
Follow us on Twitter: www.twitter.com/Covestro
Forward-looking statements
This news release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro’s public reports which are available at www.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.